domingo, 7 de julio de 2024

EU OKs First-Line Osimertinib + Chemo for EGFR+ Advanced NSCLC Drishti Agarwal July 05, 2024

https://www.medscape.com/viewarticle/eu-oks-first-line-osimertinib-chemo-egfr-advanced-nsclc-2024a1000chf

No hay comentarios:

Publicar un comentario